Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort

Background: Clinical diagnosis of Alzheimer’s disease (AD) increasingly incorporates CSF biomarkers. However, due to the intrinsic variability of the immunodetection techniques used to measure these biomarkers, establishing in-house cutoffs defining the positivity/negativity of CSF biomarkers is rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Orellana, Adelina, García-González, Pablo, Valero, Sergi, Montrreal, Laura, de Rojas, Itziar, Hernández, Isabel, Rosende-Roca, Maitee, Vargas, Liliana, Tartari, Juan Pablo, Esteban-De Antonio, Ester, Bojaryn, Urszula, Narvaiza, Leire, Alarcón-Martín, Emilio, Alegret, Montserrat, Alcolea, Daniel, Lleó, Alberto, Tárraga, Lluís, Pytel, Vanesa, Cano, Amanda, Marquié, Marta, Boada, Mercè, Ruiz, Agustín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266894/
https://www.ncbi.nlm.nih.gov/pubmed/35805894
http://dx.doi.org/10.3390/ijms23136891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266894/
https://www.ncbi.nlm.nih.gov/pubmed/35805894
http://dx.doi.org/10.3390/ijms23136891

Ejemplares similares